This inventor holds 2 USPTO granted patents. Top assignee: Kanebo, Limited. Active years: 1981-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1982
Title: Akira Suzuki: Innovator in Anti-Tumor Research
Introduction
Akira Suzuki is a notable inventor based in Tondabayashi, Japan. He has made significant contributions to the field of anti-tumor research, holding a total of 2 patents. His work focuses on innovative methods for treating bacterial cells and developing anti-tumor agents.
Latest Patents
One of his latest patents is a method for the treatment of cells of Streptococcus pyogenes. This process involves a series of steps, including pasteurization treatment, penicillin treatment, primary lyophilization, penicillin removal treatment, and secondary lyophilization to obtain an intermediary preparation. Another significant patent is a process for the cultivation of hemolytic Streptococcus pyogenes. This method emphasizes the use of a culture medium containing fermentable carbon sources while maintaining a pH of 5.6 or more during cultivation.
Career Highlights
Akira Suzuki is currently associated with Kanebo, Limited, where he continues to advance his research in the field. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
He has collaborated with notable coworkers, including Mikio Sotomura and Seiichi Iwamoto, contributing to the advancement of their shared research goals.
Conclusion
Akira Suzuki's work in anti-tumor research exemplifies the impact of innovative thinking in the medical field. His patents reflect a commitment to developing effective treatments that could benefit many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile